Arterial aging: a review of the pathophysiology and potential for pharmacological intervention. - Wikidata - wikimedia - TriplyDB

Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

http://www.wikidata.org/entity/Q37942220

about

Arterial stiffness and cognitive function in the elderly.Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?The Ten-Year History of the Asklepios Study: An Interview with Professor Ernst R. Rietzschel, Primary Investigator and Leader of the Asklepios Study.A novel system for studying mechanical strain waveform-dependent responses in vascular smooth muscle cells.

P2860

Q35037083-3AB8ED58-5968-4931-9986-36AE290F1AE8 Q35678618-8994BBE1-045B-490A-BCA8-315DB994D921 Q40298536-2ECC280F-B7F5-48F9-B354-AC8D3662B39C Q41890576-7F22AE28-7B7D-4CAA-B222-FE75D3231102

P2860

Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

http://www.wikidata.org/entity/Q37942220

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Arterial aging: a review of th ...... pharmacological intervention.

@en

Arterial aging: a review of th ...... pharmacological intervention.

@nl

type

label

Arterial aging: a review of th ...... pharmacological intervention.

@en

Arterial aging: a review of th ...... pharmacological intervention.

@nl

prefLabel

Arterial aging: a review of th ...... pharmacological intervention.

@en

Arterial aging: a review of th ...... pharmacological intervention.

@nl

P1433

Q37942220-D27E03FB-379E-44DF-B98D-320642951CCC

P1476

Q37942220-45A382A4-B9D2-4775-95B2-DEB08A245EE5

P2093

Q37942220-8DA66F05-CADC-4480-9253-4BDD658D4B57

Q37942220-931303D8-79F2-442D-8361-B90A2C8CBC57

Q37942220-A2513EEB-BA3E-4456-BE3E-54669A0B78D2

Q37942220-F4DF9161-0DA2-4E0F-B165-353F79E31556

P2860

Q37942220-031EF2C2-37DA-4AA8-AAB1-D51B366B15CE

Q37942220-0B77D81D-111F-4EF5-B859-24BFF071AF32

Q37942220-0D6AC488-0978-401D-A4FE-EE73A552829E

Q37942220-1136E4FE-EC0F-486F-A35D-F4BED6338EE9

Q37942220-137D6DE9-8563-42B9-A7C9-2AB6C930FD38

Q37942220-1C97D337-84DD-4BB0-ADE5-2801AEF2F218

Q37942220-20EC443C-7254-4745-A05A-43D86326104F

Q37942220-21D51573-C05B-46B4-93B1-C719E42ABCC7

Q37942220-286CA4B4-B13B-4B96-B99A-521788569CBD

Q37942220-2CF03F98-B281-40EA-ADC3-FF58290397C5

P2888

Q37942220-A360D32F-7451-4073-8B31-8950168878AF

P304

Q37942220-5455ACC7-E2FD-489C-AA4F-94F8F405B964

P31

Q37942220-C90FB522-E221-4290-8ACE-BA06EA5CE405

P356

Q37942220-20345D93-9BFA-4B04-84FF-6C89BC2EE7A2

P433

Q37942220-9AE43A67-5E54-44A5-ABF9-56DA8ED0B386

P478

Q37942220-8F1AF7F8-04B9-49CB-998F-49C3F6B41989

P577

Q37942220-77B04007-6A49-49E6-9F16-90EB110F3970

P5875

Q37942220-C52B2048-D7A8-4896-BD82-91F11347FC8C

P6179

Q37942220-67D88C2E-BE9A-40F9-89E8-75E8AB684082

P698

Q37942220-ECBF45EC-DC13-4AF0-A1F3-02954F70F898

P921

Q37942220-9903BB7B-3FF9-4358-8B1F-4FFEB23C05CA

Q37942220-E8138B22-21BA-47B7-9932-36E3C4FA0B89

P356

11592730-000000000-00000

P1433

P1476

Arterial aging: a review of th ...... pharmacological intervention.

@en

P2093

Audrey Adji

http://www.w3.org/2001/XMLSchema#string

Jonathan Mok

http://www.w3.org/2001/XMLSchema#string

Mayooran Namasivayam

http://www.w3.org/2001/XMLSchema#string

Michael F O'Rourke

http://www.w3.org/2001/XMLSchema#string

P2860

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Facilitated noninvasive visualization of collagen and elastin in blood vessels.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Aortic input impedance in normal man: relationship to pressure wave forms.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans.

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

P2888

11592730-000000000-00000

P304

779-795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11592730-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257906498

http://www.w3.org/2001/XMLSchema#string

P6179

1001431996

http://www.w3.org/2001/XMLSchema#string

P698

21970306

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology